Body and Mind Announces Delay in Filing Annual Financial Statements
Body and Mind (CSE: BAMM, OTC: BMMJ) has announced a delay in filing its annual financial statements for the year ended July 31, 2024. The company missed the November 28, 2024 filing deadline due to incomplete audit procedures. The delay involves pending items including final approval of external accounting memorandum, additional audit procedures, and final internal QC sign-off from the auditor. A management cease trade order has been imposed against the CEO and CFO. The company expects to file the 2024 Annual Financial Filings by December 9, 2024 and is engaging an external accounting consultant to prevent future delays.
Body and Mind (CSE: BAMM, OTC: BMMJ) ha annunciato un ritardo nella presentazione dei propri bilanci annuali per l'anno chiuso il 31 luglio 2024. L'azienda ha mancato la scadenza per la presentazione del 28 novembre 2024 a causa di procedure di audit incomplete. Il ritardo riguarda elementi in sospeso, tra cui l'approvazione finale del memorandum contabile esterno, ulteriori procedure di audit e la convalida finale della qualità interna da parte dell'auditor. È stato imposto un ordine di cessazione della negoziazione per il CEO e il CFO. L'azienda prevede di presentare i bilanci annuali 2024 entro il 9 dicembre 2024 e sta coinvolgendo un consulente contabile esterno per prevenire futuri ritardi.
Body and Mind (CSE: BAMM, OTC: BMMJ) ha anunciado un retraso en la presentación de sus estados financieros anuales para el año que terminó el 31 de julio de 2024. La compañía no cumplió con la fecha límite de presentación del 28 de noviembre de 2024 debido a procedimientos de auditoría incompletos. El retraso involucra elementos pendientes, incluidos la aprobación final del memorando contable externo, procedimientos adicionales de auditoría y la firma final de control de calidad interna por parte del auditor. Se ha impuesto una orden de cese de negociación contra el CEO y el CFO. La empresa espera presentar los informes financieros anuales de 2024 antes del 9 de diciembre de 2024 y está contratando a un consultor contable externo para evitar futuros retrasos.
Body and Mind (CSE: BAMM, OTC: BMMJ)은 2024년 7월 31일 종료 연도의 연간 재무제표 제출 지연을 발표했습니다. 이 회사는 불완전한 감사 절차로 인해 2024년 11월 28일 제출 마감일을 놓쳤습니다. 지연에는 외부 회계 메모의 최종 승인, 추가 감사 절차 및 감사자의 내부 품질 관리 최종 서명 등 보류 중인 항목이 포함됩니다. CEO와 CFO에 대해 거래 중지 명령이 발동되었습니다. 회사는 2024년 12월 9일까지 2024년 연간 재무 보고서를 제출할 것으로 예상하며, 향후 지연을 방지하기 위해 외부 회계 컨설턴트를 고용하고 있습니다.
Body and Mind (CSE: BAMM, OTC: BMMJ) a annoncé un retard dans le dépôt de ses états financiers annuels pour l'année se terminant le 31 juillet 2024. La société a raté la date limite de dépôt du 28 novembre 2024 en raison de procédures d'audit incomplètes. Le retard concerne des éléments en attente, y compris l'approbation finale du mémorandum comptable externe, des procédures d'audit supplémentaires et la validation finale de la qualité interne par l'auditeur. Un ordre de cessation de négociation a été imposé au PDG et au directeur financier. L'entreprise prévoit de soumettre les états financiers annuels 2024 d'ici le 9 décembre 2024 et engage un consultant comptable externe pour éviter de futurs retards.
Body and Mind (CSE: BAMM, OTC: BMMJ) hat eine Verzögerung bei der Einreichung seiner Jahresabschlüsse für das am 31. Juli 2024 endende Geschäftsjahr bekannt gegeben. Das Unternehmen hat die Frist für die Einreichung am 28. November 2024 aufgrund unvollständiger Prüfungsunterlagen verpasst. Die Verzögerung betrifft ausstehende Punkte, einschließlich der endgültigen Genehmigung des externen Rechnungslegungsmemorandums, zusätzlicher Prüfungsverfahren und der endgültigen internen Qualitätskontrolle durch den Prüfer. Gegen den CEO und CFO wurde eine Handelsaussetzung angeordnet. Das Unternehmen erwartet, die Jahresfinanzberichte 2024 bis zum 9. Dezember 2024 einzureichen, und engagiert einen externen Rechnungswesenberater, um zukünftige Verzögerungen zu verhindern.
- Company is taking proactive steps by engaging external accounting consultant to prevent future filing delays
- Missed regulatory deadline for filing annual financial statements
- Management cease trade order imposed against CEO and CFO
- Audit process remains incomplete despite being substantially done
- Need for additional resources indicates potential internal control weaknesses
Las Vegas, Nevada and Vancouver, British Columbia--(Newsfile Corp. - November 29, 2024) - Body and Mind Inc. (CSE: BAMM) (OTC Pink: BMMJ) (the "Company" or "BaM") wishes to announce that its annual financial statements for the year ended July 31, 2024, including the related management discussion and analysis, and certifications of the Chief Executive Officer and Chief Financial Officer (collectively, the "2024 Annual Financial Filings") will not be filed as required under Canadian securities legislation by the required filing deadline of November 28, 2024.
In discussion with its auditors, the Company has determined that it is not able to meet the November 28, 2024 filing deadline (the "Filing Deadline") under Canadian securities legislation for the 2024 Annual Financial Filings. Although the audit process is substantially complete, the additional financial procedures include (i) final approval of an external accounting memorandum for the auditor, (ii) application of additional audit procedures (as needed) to assess independent conclusions, and (iii) final internal QC sign-off from the auditor. Therefore, the Company is not able to meet the Filing Deadline for the 2024 Annual Financial Filings. The Company is in the process of engaging an external accounting consultant to add to the Company's resources in order to achieve future filing deadlines.
The Company has applied to the applicable Canadian securities regulatory authorities and received a management cease trade order related to the Company's securities to be imposed against the Chief Executive Officer and Chief Financial Officer of the Company to trade securities of the Company. The management cease trade order will be in effect until the 2024 Annual Financial Filings are filed, and requires that the 2024 Annual Financial Filings be filed on or around December 9, 2024.
Until the 2024 Annual Financial Filings are filed, the Company intends to provide information in accordance with National Policy 12-203 Management Cease Trade Orders.
About Body and Mind Inc.
BaM is an operations-focused cannabis company which operates retail cannabis dispensaries in California and Illinois, and pending retail operations in Illinois and New Jersey. We work daily to increase our market share through delighting customers while also continuing to hone our operational efficiencies to drive profits. We are primarily guided by the metric of return on investment. Currently, we believe the most significant return on investment projects in front of us are successful retail cannabis store launches in Illinois and New Jersey, which augment our existing retail footprint.
Please visit www.bodyandmind.com for more information.
Twitter: @bodyandmindBaM
For further information, please contact:
Company Contact:
Michael Mills
President and CEO
Tel: 800-361-6312
ir@bamcannabis.com
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Safe Harbor Statement
Except for the statements of historical fact contained herein, the information presented in this news release constitutes "forward-looking statements" as such term is used in applicable United States and Canadian laws. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management, a well as the timing for preparation and filing of the 2024 Annual Financial Filings, and the timing and duration of the management cease trade order under National Policy 12-203. Any other statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as "expects" or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans, "estimates" or "intends", or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved) are not statements of historical fact and should be viewed as "forward-looking statements". Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such risks and other factors include, among others, the actual results of activities, variations in the underlying assumptions associated with the estimation of activities, the availability of capital to fund programs and the resulting dilution caused by the raising of capital through the sale of shares, accidents, labor disputes and other risks. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements contained in this news release and in any document referred to in this news release.
Certain matters discussed in this news release and oral statements made from time to time by representatives of the Company may constitute forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved. Forward-looking information is subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the Company's ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise. This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/232009
FAQ
When will Body and Mind (BMMJ) file its 2024 annual financial statements?
What consequences did Body and Mind (BMMJ) face for missing the filing deadline?